Targeting HSP90 in breast cancer: ENCHANT-1 (NCT01677455) phase 2 proof of concept study of ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer (TNBC)
Authors: Cameron, D., Spector, N., Gomez, H., Hickish, T., Vandat, L., Kim, S.B., Sheldon, E., El-Hariry, I., Perez, E. and Awada, A.
Journal: EUROPEAN JOURNAL OF CANCER
Volume: 50
Pages: S98
eISSN: 1879-0852
ISSN: 0959-8049
Source: Web of Science (Lite)
Preferred by: Tamas Hickish